Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan S Go

Showing results (401-410 of 571) with videos related to

Pageof 58
Sort By:
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 9, 2017
Longitudinal Weight Change During CKD Progression and Its Association With Subsequent MortalityElaine Ku, Joel D Kopple, Kirsten L Johansen, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|September 24, 2009
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposureJoan C Lo, Felice S O'Ryan, Nancy P Gordon, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2024
Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKIPavan K Bhatraju, Leila R Zelnick, Ian B Stanaway, et al.
Chest|February 9, 2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn J You, Daniel E Singer, Patricia A Howard, et al.
Contemporary Clinical Trials|June 8, 2024
Rationale and design of the KP ENRICH trial: A food is medicine intervention in low-income high-risk adults with diabetes within Kaiser PermanenteRishi V Parikh, Claudia L Nau, Thida C Tan, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2017
Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)Archna Bajaj, Scott M Damrauer, Amanda H Anderson, et al.
Pageof 58

Showing results (401-410 of 571) with videos related to

Sort By:
Pageof 58
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 9, 2017
Longitudinal Weight Change During CKD Progression and Its Association With Subsequent MortalityElaine Ku, Joel D Kopple, Kirsten L Johansen, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|September 24, 2009
Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposureJoan C Lo, Felice S O'Ryan, Nancy P Gordon, et al.
American Heart Journal|July 29, 2014
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registryBenjamin A Steinberg, Rosalia G Blanco, Donna Ollis, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2024
Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKIPavan K Bhatraju, Leila R Zelnick, Ian B Stanaway, et al.
Chest|February 9, 2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn J You, Daniel E Singer, Patricia A Howard, et al.
Contemporary Clinical Trials|June 8, 2024
Rationale and design of the KP ENRICH trial: A food is medicine intervention in low-income high-risk adults with diabetes within Kaiser PermanenteRishi V Parikh, Claudia L Nau, Thida C Tan, et al.
The American Journal of Medicine|January 23, 2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery DiseaseRenato D Lopes, Meena Rao, DaJuanicia N Simon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2017
Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)Archna Bajaj, Scott M Damrauer, Amanda H Anderson, et al.
Pageof 58